Buradasınız

Anasayfa » Content

Transplante Böbrekte 29 yıl Sonra Renal Hücreli Karsinoma: Bir Olgu Sunumu ve Literatürün Gözden Geçirilmesi

Renal Cell Carcinoma in a Transplanted Kidney After 29 Years: A Case Report and Review of the Literature

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2012
DOI: 
DOI 10.5262/tndt.2012.1003.17

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
Primary renal cell carcinoma (RCC) is the most common kidney cancer. In renal transplant patients, RCC more commonly arises in the native kidneys, whereas allograft involvement has seen rarely. A 65-year-old man developed an RCC in the grafted kidney 29 years after transplantation. Histologic and immunohistochemical studies diagnosed RCC. Renal transplant patients’ native and graft kidneys must be followed by regular ultrasonography.
Bookmark/Search this post with
Abstract (Original Language): 
Primer renal hücreli karsinoma (RCC) en sık görülen böbrek kanseridir. Renal transplantlı hastalarda, genellikle kendi böbreklerinde RCC gelişmekte olup nadiren de olsa allogreft böbrekte de gelişebilmektedir. 65 yaşında erkek hastada greft böbrekte transplanttan 29 sene sonra RCC saptandı. Histolojik ve immünohistokimyasal çalışmalar ile RCC tanısı kondu. Renal transplantlı hastaların kendi ve greft böbrekleri düzenli olarak ultrasonografi ile takip edilmelidir
FULL TEXT (PDF): 
PDF icon arastrmx_172977_21_pp_295-297.pdf
  • 3
295-297
  • Turkish

REFERENCES

References: 

1. Penn I: Primary kidney tumours before and after renal transplantation.
Transplantation 1995; 59: 480-485
2. Moudouni SM, Lakmichi A, Tligui M, Rafi i A, Tchala K, Haab F,
Gattegno B, Thibault P, Doublet JD: Renal cell carcinoma of native
kidney in renal transplant recipients. BJU Int 2006; 98: 298-302
3. Penn I: Cancers in renal transplant recipients. Adv Ren Replace
Ther 2000; 7: 147-156
4. Scandling JD: Acquired cystic kidney disease and renal cell cancer
after transplantation. Time to rethink screening? Clin J Am Soc
Nephrol 2007; 2: 621-622
5. Hurst FP, Jindal RM, Graham LJ, Falta EM, Elster EA, Stackhouse
GB, Agodoa LY, Lentine KL, Salifu MO, Abbott KC: Incidence,
predictors, costs and outcome of renal cell carcinoma after kidney
transplantation: USRDS experience. Transplantation 2010; 90:
898-904
6. Rouprêt M, Peraldi MN, Thaunat O, Chrétien Y, Thiounn N, Dufour
B, Kreis H, Méjean A: Renal cell carcınoma of the grafted Kidney:
How to improve screening and graft tracking. Transplantation 2004;
77: 146-148
7. Dhote R, Thiounn N, Debre B, Vidal-Trecan G: Risk factors for
adult renal cell carcinoma. Urol Clin N Am 2004; 31: 237-247
8. Barama A, St-Louis G, Nicolet V, Hadjeres R, Daloze P: Renal cell
carcinoma in kidney allografts: A case series from a single center.
Am J Transplant 2005; 5: 3015-3018
9. Walton TJ, McCulloch TA, Bishop MC: Aggressive renal cell
carcinoma in a 27-year-old kidney transplant. Nephrol Dial
Transplant 2005; 20: 1018-1019
10. Jordan YZ Li, Tuck Y. Yong, Mohan Rao, P. Toby H. Coates: Partial
nephrectomy for renal cell carcinoma in an allograft kidney with
limited functional reserve. NDT Plus 2009; 2: 312-313
11. Ribal MJ, Rodriguez F, Musquera M, Segarra J, Guirado L,
Villavicencio H, Alcaraz A: Nephron-sparing surgery for renal
tumor: A choice of treatment in an allograft kidney. Transplant Proc
2006; 38: 1359-1362

Thank you for copying data from http://www.arastirmax.com